The document discusses hazards related to parenteral therapy. It introduces parenteral therapy as injectable routes of administration. It then discusses several hazards including sepsis, toxemia, thrombosis, phlebitis, particulate matter hazards, incompatibilities between formulations, and hazards from overdose or air embolism. The document provides detailed explanations of each hazard with examples.

1. HAZARDS RELATED TO
PARENTERAL THERAPY
Presented by:
Mrs. Arti R. Rajput,
M.pharm
(SUCOP,Pune)

2. CONTENT
 Introduction to parenteral therapy.
 Reason related to hazards.
 Hazards associated parenteral therapy.

3. INTRODUCTION
 Parenteral refers to injectable routes of administration.
 Para means, “outside” and enteron means intestinal.
 Injections should be sterile because they are placed in direct
contact with internal body fluid or tissue where infection can
easily occurred.
 Injections are the preparation which are injected through skin or
mucous membrane directly into a blood vessels ,tissue , or
organ.

4. REASONS
 Hazards may be because of following ,
 1) Inadequacy in the manufacturing of product.
 2) Inadequacy during transport , storage , and
handling.
 3) Inadequacy during administration.

5. HAZARDS ASSOCIATED WITH
PAR.
 1) SEPSIS
It results from microorganisms contamination the
product or delivery system prior to or during use or from
microorganism precipitation on patient skin.
e.g. – S. aureus.
-Sepsis may be localized (abscess) or systemic (septicaemia).
-In line bacterial filters remove the contamination. However , they
are costly affect flow rate and may sometimes get blocked.
- Common contamination are S.epidermidis , candida spp. , E.coli,
Enterobacteria , proteus klebsiella , Pseudomonas.

6. HAZARDS
 2) TOXEMIA
It is due to biological toxin contaminating the product
Endotoxins of gram –ve bacteria cause ,
i)rise in body temp.,
ii)shivering ,
iii)vasoconstriction ,
iv) increase in B.P. ,
v)respiratory depression ,
vi) pain in joint. & back, headache, nausea etc.

7. HAZARDS
 TOXEMIA
- Even refrigerated product may be contaminated with product
that produces endotoxin ( Psechrophillic bacteria) .
- Injectable contaminated by S. aureus may results in toxic shock
syndrome.
- Aspergillus flarus is a fungus produces a toxin , the infusion of
within may cause sudden death.

8. HAZARDS
 3) THROMBOSIS
It occurs with i.v. infusion and may cause
following complications,
-i) emboli formed may reach lungs causing pulmonary thrombosis
-ii) secondary infection may cause septicaemia.
- Thrombosis of artery is more serious than that of vein as it may
cause gangrene of concerned organ.

9. HAZARDS
 4) PHLEBITIS
It occurs with i.v. infusion . It may or may not be
associated with infection or may or may not result in
thrombosis.
5) BLEEDING
It occurs if blood vessel is damaged by needle or if
patient has platelet deficiency called haemophilia.

10. HAZARDS
 6) PARTICULATE MATTER HAZARDS
Particles > 7 um are more
dangerous than smaller ones. Particulate matter may cause
occlusion of capillaries and blood vessels resulting in ischemia
and necrosis of tissue.
Thrombosis and embolism , phlebitis , thrombophlebitis ,
allergenic reaction , neoplastic response , pain and
inflammation.

11. HAZARDS
 7) HAZARDS DUE TO PHYSICOCHEMICAL PROPERTIES OF
FORMULATION
pH and osmotic pressure of formulation may
have damaging effect on tissue.
8) HYPERSENSITIVITY
Hypersensitivity reaction because of drug
itself, these may be immediate or delayed type.

12. HAZARDS
 9) Overdose of drug and overload of fluid from i.v.
administration.
 10) AIR EMBOLI
Emboli occur with i.v. infusion without alarm system
is used. As little as 10 ml of air may be fatal .
-care should be taken to remove all air bubble from the syringe or
i.v. line prior to starting the infusion.

13. HAZARDS
 11) FEVER
It may be due to abscess produced by i.m. injection or
due to injection of pyrogenic material or due to hypersensitivity
reaction.
12)INFILTRATION AND EXTRAVASATION
Infiltration is unintentional infusion of sub.
Into a tissue. Extravas is leakage of a sub. From vessel into
surrounding tissue. Hypertonic Dextrose KCl solution and
extreme of pH may cause considerable pain if extravasatn occur
infection , phlebitis, thrombosis.

14. HAZARDS
 13)HAZARDS DUE TO INCOMPATIBILITY
Intravenous admixture incompatibility could be fatal
because of formation of toxic substance.
 PARENTRAL ADMIXTURE INCOMPATIBILITY
- Admixture : when two or more parenteral combines, resulting
mixture is admixture.
-Additive : when SVP is added to LVP , the added SVP is called
additive.

15. HAZARDS
 PARENTRAL ADMIXTURE INCOMPATIBILITY
Parenteral admixture are used because,
1) Physician prescribes administration of several drug combining
the drug and administering them several time and resulting
in inconvenience .
2) The no. of pricking to the patient is reduced.
 PARENTRAL INCOMPATIBILITY
There are physical ,chemical ,or therapeutic problems that’s arise
when parenteral drugs are combined and admin. by injection.

16. HAZARDS
PARENTRAL INCOMPATIBILITY
Problems of parenteral admixture incompatibility is of concern
because ,
1)There is increase use of parenteral in therapeutics.
2)Several parenteral formulations are available in the market
3)There is increase use of LVP as vehicle of SVP.
4)Formulation are available in different drug.
5)Order of mixture of parenteral at the time of administration may
be important.
6)Delayed incompatibility may possible

17. HAZARDS
 Parenteral admixture incompatibility may lead to following
hazards.
1)The patient may not receive the full therapeutic effect of
mixture.
2)Toxic decomposition product may result.
3)There may be irritation of vein or occlusion of vessels.

18. TYPES OF INCOMPATIBILITY
 Types of incompatibility
1)Physical incompatibility
2)Chemical incompatibility
3)Therapeutic incompatibility
 Two formulations combined together to show antagonistic or
synergistic action.
e.g. – 1) warfarin + phytonadione = antagonistic action
2) Ca2+ + Digoxin
= synergistic action

19. PHYSICAL INCOMPATIBILITY
 This may result in to change in colour ,precipitation formation or
evolution of gas.
 E.g. – 1) phenytoin sodium inj + LVP of acidic pH (dextrose)
In this reaction phenytoin get precipitate.
2) diazepam inj + LVP
In this precipitation of diazepam is observed.
3) sodium phenobarbitone + LVP of acidic pH (dextrose)
in this reaction phenobarbitone get precipitate.

20. CHEMICAL INCOMPATIBILITY
 This may be due to ,
1)Hydrolysis
2)Oxidation
3)Reduction or
4)Complexsation.
e.g. – 1)carbecilline inj + gentamycin inj =inactivation of
gentamycin.
2) ascorbic acid inj (low pH) +LVP containing penicillin=
penicillin deactivate due to low pH.

21. CHEMICAL INCOMPATIBILITY
3) Tetracycline inj + Ca2+ (ringer sol) = activity reduced by
Complexsation

22. INCOMPATIBILITY
 Mixing of two injection may also lead the following
1)Adjuvant – adjuvant interaction
2)Antioxidant may get diluted and hence drug may undergo
oxidation
3)N2 atom may be loss.
4)Light sensitive drugs may be affected.

23. SUMMARY

24. SUMMARY

25. SUMMARY

26. SUMMARY

27. SUMMARY

28. SUMMARY

29. SUMMARY

31. SUMMARY

32. SUMMARY

33. SUMMARY